Novartis Gains Permission From US to Test Hydroxychloroquine Against COVID-19

An arrangement of hydroxychloroquine pills in Las Vegas, Nev., on April 6, 2020. John Locher/AP Photo

Swiss drugmaker Novartis gained permission from the U.S. Food and Drug Administration to test hydroxychloroquine, a malaria drug being widely used against COVID-19, against the new disease from China.

COVID-19 is caused by the CCP (Chinese Communist Party) virus, a novel coronavirus.